Trust Company of Vermont’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,000
Closed -$28.2K 830
2023
Q1
$28.2K Hold
1,000
﹤0.01% 561
2022
Q4
$26.1K Hold
1,000
﹤0.01% 550
2022
Q3
$22K Hold
1,000
﹤0.01% 589
2022
Q2
$30K Buy
+1,000
New +$28.7K ﹤0.01% 526
2022
Q1
Sell
-1,000
Closed -$23K 323
2021
Q4
$23K Buy
+1,000
New +$26.3K ﹤0.01% 565
2021
Q3
Sell
-1,000
Closed -$25K 315
2021
Q2
$25K Hold
1,000
﹤0.01% 541
2021
Q1
$19K Hold
1,000
﹤0.01% 559
2020
Q4
$20K Hold
1,000
﹤0.01% 543
2020
Q3
$17K Hold
1,000
﹤0.01% 545
2020
Q2
$19K Buy
+1,000
New +$16.2K ﹤0.01% 539
2017
Q4
Sell
-51
Closed -$3K 976
2017
Q3
$3K Hold
51
﹤0.01% 854
2017
Q2
$3K Buy
+51
New +$2.96K ﹤0.01% 875

Other funds holding ALKS

Trust Company of Vermont's ALKS Position: Q2 2023 in Review

Trust Company of Vermont sold out of Alkermes (ALKS) in Q2 2023, closing a stake of 1,000 shares — an estimated $28.2K sold.

Trust Company of Vermont first reported a position in ALKS in Q2 2017 and held it in 12 quarters. The position peaked at $30K in Q2 2022. 292 funds tracked by Wall St. Rank hold ALKS as of Q2 2023.

  • Trust Company of Vermont reported no remaining Alkermes position as of Q2 2023 after selling out during the quarter.
  • Trust Company of Vermont sold 1,000 Alkermes shares in Q2 2023, an estimated $28.2K.
  • Trust Company of Vermont first reported a position in Alkermes in Q2 2017 and held it in 12 quarters.
  • Trust Company of Vermont's Alkermes position peaked at $30K in Q2 2022.
  • 292 funds tracked by Wall St. Rank held Alkermes as of Q2 2023.

Based on Trust Company of Vermont's 13F filing for Q2 2023, filed 17 Jul 2023.